Golden
LoginSign Up
Hyasynth

Hyasynth

A biology company based in Montreal, Canada with a main focus is on engineering microbes for the manufacturing of pharmaceuticals and other products, specifically cannabinoids including THC.

Instead of growing plants to make cannabinoids, Hyasynth engineer strains of yeast to produce it. After the yeast strains grows, they isolate pure cannabinoids for research, or for products like oils and pills.

Hyasynth is a Licensed Dealer under the Narcotic Control Regulations of Health Canada. Under these regulations, Hyasynth is permitted to produce and distribute cannabinoid products to those that are also legally allowed to possess cannabinoid products.

Their stated goal is to create a new way of producing cannabinoids that doesn't depend on growing plants or doing synthetic chemistry.

There are many cannabinoids, terpenes and combinations of these compounds.

Hyasynth has raised over $1M. The lead investors were Anges Quebec, a local angel network that put in $392,000 from its members and their first round of investors, which include SOSV, Ethan O. Perlstein (CEO of Perlara), and Andrew Hessel from Autodesk.

Timeline

People

Name
Role
Related Golden topics

Further reading

Title
Author
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References